AMLX
Price
$8.21
Change
-$0.13 (-1.56%)
Updated
Jul 21, 03:46 PM (EDT)
Capitalization
743.44M
17 days until earnings call
RLFTY
Price
$3.00
Change
-$0.07 (-2.28%)
Updated
Jul 17 closing price
Capitalization
34.77M
Interact to see
Advertisement

AMLX vs RLFTY

Header iconAMLX vs RLFTY Comparison
Open Charts AMLX vs RLFTYBanner chart's image
Amylyx Pharmaceuticals
Price$8.21
Change-$0.13 (-1.56%)
Volume$4.44K
Capitalization743.44M
RELIEF THERAPEUTICS HLDG AG
Price$3.00
Change-$0.07 (-2.28%)
Volume$155
Capitalization34.77M
AMLX vs RLFTY Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. RLFTY commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and RLFTY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (AMLX: $8.34 vs. RLFTY: $3.00)
Brand notoriety: AMLX and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 75% vs. RLFTY: 19%
Market capitalization -- AMLX: $743.44M vs. RLFTY: $34.77M
AMLX [@Biotechnology] is valued at $743.44M. RLFTY’s [@Biotechnology] market capitalization is $34.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than RLFTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while RLFTY’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 3 bearish.
  • RLFTY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than RLFTY.

Price Growth

AMLX (@Biotechnology) experienced а +8.59% price change this week, while RLFTY (@Biotechnology) price change was -0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($743M) has a higher market cap than RLFTY($34.8M). AMLX YTD gains are higher at: 120.635 vs. RLFTY (-38.776).
AMLXRLFTYAMLX / RLFTY
Capitalization743M34.8M2,135%
EBITDA-206.81MN/A-
Gain YTD120.635-38.776-311%
P/E Ratio2.81N/A-
Revenue-1.27MN/A-
Total Cash204MN/A-
Total Debt1.38MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXRLFTY
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 15 days ago
43%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 11 days ago
49%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATHDX31.280.16
+0.51%
American Century Heritage R6
QQMNX21.550.10
+0.47%
Federated Hermes MDT Market Neutral IS
GLVAX84.57-0.02
-0.02%
Invesco Global Focus A
DNLVX20.66-0.01
-0.05%
Dunham Large Cap Value N
JHFEX13.18-0.04
-0.30%
JHancock Fundamental Equity Inc I

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+0.72%
GRI - AMLX
57%
Loosely correlated
-6.67%
SLRX - AMLX
54%
Loosely correlated
+0.26%
RGNX - AMLX
45%
Loosely correlated
-6.10%
DNLI - AMLX
44%
Loosely correlated
-3.65%
CCCC - AMLX
44%
Loosely correlated
+6.42%
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
N/A
RLFTF - RLFTY
47%
Loosely correlated
-3.60%
AMLX - RLFTY
25%
Poorly correlated
+0.72%
ORKA - RLFTY
24%
Poorly correlated
-5.34%
SNGX - RLFTY
22%
Poorly correlated
+0.74%
TARS - RLFTY
22%
Poorly correlated
+4.47%
More